Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 3, 2014, Pages

  Soon, Yu Yang ^a   Tham, Ivan Weng Keong ^a   Lim, Keith H ^a   Koh, Wee Yao ^a   Lu, Jiade J ^b  

^a National University Cancer Institute   (Singapore)

^b Shanghai Proton and Heavy Ion Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN METASTASIS; BRAIN SURGERY; CANCER GROWTH; CANCER RADIOTHERAPY; COGNITION; FATIGUE; HEADACHE; HUMAN; META ANALYSIS; NAUSEA; NEUROTOXICITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RADIOSURGERY; REVIEW; SEIZURE; SYSTEMATIC REVIEW; VOMITING; WHOLE BRAIN RADIOTHERAPY; BRAIN TUMOR; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; METASTASIS; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKULL IRRADIATION;

BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DISEASE-FREE SURVIVAL; HUMANS; RADIOSURGERY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84904645054     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009454.pub2     Document Type: Review

References (53)

1. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al.Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactiv Radiosurgery alone for Treatment of Brain Metastases. The Journal of the American Medical Association 2006;295(21):2483-90.
2. Chang E, Wefel J, Hess K, Allen P, Lang F, Kornguth D, et al.Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncology 2009;10(11):1037-44.
3. Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert B, et al.Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: Results of the EORTC 22952-26001 Study. Journal of Clinical Oncology 2011;29(2):134-41.
4. Patchell R, Tibbs P, Regine W, Dempsey R, Mohiuddin M, Kryscio R, et al.Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain. The Journal of the American Medical Association 1998;280(17):1485-9.
5. Roos D, Writh A, Burmeister B, Spry N, Drummond K, Beresford J, et al.Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: Mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05). Radiotherapy and Oncology 2006;80(3):318-22.
6. Chougule P, Burton-Williams M, Saris S, Zheng Z, Ponte B, Noren G, et al.Randomized treatment off brain metastasis with gamma knife radiosurgery, whole brain radiotherapy or both. International Journal of Radiation Oncology Biology and Physics. 2000; Vol. 48:114.
7. Fogarty G, Morton R, Vardy J, Nowak A, Mandel C, Forder P, et al.Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial. BMC Cancer 2011;11(142):1-8.
8. ACTRN12607000512426 . Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma - A randomised phase III trial. www.anzctr.org.au/ACTRN12607000512426.aspx (accessed 11 October 2011).
9. NCT00377156 . Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases. clinicaltrials.gov/ct/show/NCT00377156 (accessed 11 October 2011).
10. Al-Shamy G, Sawaya R. Management of brain metastases: the indispensable role of surgery. Journal of Neuro-Oncology 2009;92(3):275-82.
11. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al.Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of RTOG 9508 randomised trial. Lancet 2004;363:1665-72.
12. Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, et al.Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. International Journal of Radiation Oncology Biology and Physics 2007;68(5):1388-95.
13. Brown P, Asher A, Farace E. Adjuvant whole brain radiotherapy: strong emotions decide but rational studies are needed. International Journal of Radiation Oncology, Biology, Physics 2008;70(5):1305-9.
14. DeAngelis L, Delattrre JY, Posner J. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989;39(6):789-96.
15. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care: Meta-analysis in Context. 2nd Edition. London: BMJ Publication Group, 2001.
16. DerSimonian R, Laird N. Meta-analyses in clinical trials. Controlled Clinical Trials 1986;7:177-88.
17. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al.Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. International Journal of Radiation Oncology, Biology, Physics 1997;37(4):745-51.
18. Gavrilovic IT, Poser JB. Brain metastases: epidemiology and pathophysiology. Journal of Neuro-Oncology 2005;75(1):5-14.
19. GRADE Working Group. Guideline Development Tool. McMaster University and Synaway.com, 2012.
20. Hart MG, Grant R, Walker M, Dickinson HO. Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastases. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD003292.pub2]
21. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7416):557-60.
22. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, March 2011.
23. Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D. Global Cancer Statistics. CA: A Cancer Journal for Clinicians 2011;61:69-90.
24. Kalkanis S, Kondziolka D, Gaspar L, Burri S, Asher A, Cobbs C, et al.The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical guidelines. Journal of Neuro-oncology 2010;96:33-43.
25. Khuntia D, Brown P, Li J, Mehta MP. Whole-brain radiotherapy in the management of brain metastasis. Journal of Clinical Oncology 2006;24(8):1295-304.
26. Li J, Bentzen SM, Renschler M, Mehta M. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. Journal of Clinical Oncology 2007;25(10):1260-6.
27. Linskey M, Andrews D, Asher A, Burri S, Kondziolka D, Robinson P, et al.The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guidelines. Journal of Neuro-Oncology 2010;96:45-68.
28. Mamon HJ, Yeap BY, Janne PA, Reblando J, Shrager S, Jaklitsch MT, et al.High risk of brain metastases in surgically staged IIIA non-small cell lung cancer patients treated with surgery, chemotherapy and radiation. Journal of Clinical Oncology 2005;23(7):1530-7.
29. McHaffie DR, Kuntia D, Suh JH, Tome W, Mehta MP. Stereotactic Irradiation: Linear accelerator and Gamma knife. In: Gunderson LL, Tepper JE editor(s). Clinical Radiation Oncology. 3rd Edition. Saunders, 2012:331-43.
30. Mehta MP, Tsao MN, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, et al.The American Society of Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. International Journal of Radiation Oncology, Biology, Physics 2005;63(1):37-46.
31. Meyers CA, Wefel JS. The use of the Mini-Mental State Examination to assess cognitive function in cancer trials: No, Ifs, Ands, Buts, or Sensitivity. Journal of Clinical Oncology 2003;21(19):3557-8.
32. Meyers CA, Brown PD. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. Journal of Clinical Oncology 2006;24(8):1305-09.
33. National Comprehensive Cancer Network. Central Nervous System Cancers. http://www.nccn.org/professionals/physician_gls/pdf/cns.pdf 2012; Vol. Version I.2012.
34. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
35. Paterson AH, Agarwal M, Lees A, Hanson J, Szafran O. Brain metastases in breast cancer patients receiving adjuvant chemotherapy. Cancer 1982;49(4):651-4.
36. Patil CG, Pricola K, Garg SK, Bryant A, Black KL. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. Cochrane Database of Systematic Reviews 2010, Issue 6. [DOI: 10.1002/14651858.CD006121.pub2]
37. Platta CS, Khuntia D, Mehta MP, Suh JH. Current treatment strategies for brain metastasis and complications from therapeutic techniques: a review of current literature. American Journal of Clinical Oncology 2010;33(4):398-407.
38. Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerback AD. A note on competing risks in survival data analysis. British Journal of Cancer 2004;91:1229-35.
39. Smedby KE, Brandt L, Backlund ML, Blomqvist P. Brain metastases admissions in Sweden between 1987 and 2006. British Journal of Cancer 2009;101(11):1919-24.
40. Soffietti R, Kocher M, Abacioglu U, Villa S, Fauchon F, Baumert B, et al.A European Organization for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: Quality of life results. Journal of Clinical Oncology 2013;31:65-72.
41. Sperduto PW, Berkey B, Gaspar L, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1960 patients in the RTOG database. International Journal of Radiation Oncology, Biology, Physics 2008;70(2):510-4.
42. Stafinski T, Jhangri GS, Yan E, Menon D. Effectiveness of stereotactic radiosurgery alone or in combination with whole brain radiotherapy compared to conventional surgery and/or whole brain radiotherapy for the treatment of one or more brain metastases: a systematic review and meta-analysis. Cancer Treatment Reviews 2006;32(3):203-13.
43. Stewart LA, Parmar MKB. Meta-analysis of the literature or of individual patient data: is there a difference?. Lancet 1993;341:418-22.
44. Suh JH, Videtic GM, Aref AM, Germano I, Goldsmith BJ, Imperato JP, et al.ACR Appropriateness Criteria: single brain metastasis. Current Problems in Cancer 2010;34(3):162-74.
45. Suh JH. Stereotactic radiosurgery for the management of brain metastases. The New England Journal of Medicine 2010;362(12):1119-27.
46. Sundermeyer ML, Meropol NJ, Rogatko A, Wang H, Cohen SJ. Changing patterns of bone and brain metastases in patients with colorectal cancer. Clinical Colorectal Cancer 2005;5(2):108-13.
47. Thomas AJ, Rock JP, Johnson CC, Weiss L, Jacobsen G, Rosenblum M. Survival of patients with synchronous brain metastases: an epidemiological study in southeastern Michigan. Neurosurgical Focus 2000;9(2):1-5.
48. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8:16.
49. Tsao MN, Lloyd N, Wong RKS, Chow E, Rakovitch E, Laperriere N, Xu W, Sahgal A. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD003869.pub3]
50. Tsao M, Xu W, Sahgal A. A Meta-Analysis Evaluating Stereotactic Radiosurgery, Whole-Brain Radiotherapy, or Both for Patients Presenting with a Limited Number of Brain Metastases. Cancer 2012;118:2486-93.
51. Tsao M, Rades D, Wirth A, Lo S, Danielson B, Gaspar L, et al.Radiotherapeutic and surgical management for newly diagnosed brain metastasis (es): An American Society for Radiation Oncology evidence-based guideline. Practical Radiation Oncology 2012;2:210-25.
52. Vogelbaum MA, Suh JH. Resectable brain metastases. Journal of Clinical Oncology 2006;24(8):1289-94.
53. Wen PY, Loeffler JS. Overview of the clinical manifestations, diagnosis and management of patients with brain metastases. In: Basow DS editor(s). Uptodate. Waltham: Uptodate, 2011.